Share
   
Title
Code
Session Type
Venue
Date Time
Chair:
Organizer:

Despite the progress that has been made in recent years in the fight against HIV/AIDS, there are still 1.8 million AIDS-related deaths and 2.7 million new infections every year. Access to HIV diagnostics to determine HIV infection is one of the major bottlenecks to timely treatment initiation in children and adults. Diagnostics for early infant diagnosis (EID) and viral load (VL) screening to monitor viral suppression have been historically offered using complex technologies, requiring test results to be sent away to central laboratories. Some HIV positive clients can wait for weeks or even months to receive test results, causing delays in treatment initiation.
Complementing conventional laboratory platforms with simplified technologies, like GeneXpert that can be used at lower levels of care, will help to close these gaps that currently lead to poorer health outcomes, higher treatment costs, and further spread of disease.
The availability of polyvalent near-care (NC) and point-of-care (POC) diagnostics platforms for TB, HIV, HCV and HPV testing capabilities provides the opportunity to integrate programs.
Target audience:  Medical technicians/scientists, treating physicians, NGOs, policy makers and donors 
Learning Outcomes:
 Increased understanding of:

  1. key challenges and opportunities for implementation of POC/near patient diagnostics for HIV EID and VL in resource limited settings
  2. the impact of near patient testing using GeneXpert
  3. Consolidation of diagnostics using a single platform
 

10:15
MOSA2001
Economic and Public Health Impact Of Decentralised HIV Viral Load Testing in Kenya
Margreet De Necker, TCD Outcomes Research, South Africa
Slides
10:35
MOSA2002
Point of care viral load testing to facilitate differentiated HIV care in South Africa
Nigel Garrett, CAPRISA, South Africa
Slides
10:55
MOSA2003
Impact of early initiation of ART following in utero HIV infection
Jane Millar, HIV Pathogenesis Programme, South Africa
Slides
11:15
MOSA2004
Leveraging on GeneXpert’s expanded assay menu for the integrated management of HIV/HCV/TB co-infections: field experience from MSF
Emmanuel Fajardo, Médecins Sans Frontières (MSF) Access Campaign, Switzerland
Slides
11:35
MOSA2005
Detecting acute HIV infection in vulnerable populations: FRESH study
Thumbi Ndung'u, KRITH UKZN, South Africa
Slides